Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.09 USD | -1.43% | -6.50% | -39.59% |
04-25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
04-25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.59% | 799M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- RBC Cuts Price Target on Sage Therapeutics to $48 From $52, Maintains Sector Perform, Speculative Risk Rating